Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bial and Eisai confirm effectiveness of epilepsy monotherapy Zebinix
Image: Bial’s eslicarbazepine acetate monotherapy proven to be clinically effective for focal-onset epilepsy compared to its use as adjunctive therapy. Photo: courtesy of BIAL.
Image: Bial’s eslicarbazepine acetate monotherapy proven to be clinically effective for focal-onset epilepsy compared to its use as adjunctive therapy. Photo: courtesy of BIAL.